Introduction
Hyaline cartilage is a highly specialized tissue, with a unique three-dimensional structure that enables it to withhold tremendous mechanical forces inflicted during joint movement and a smooth surface allowing nearly frictionless contact between articulating joint surfaces. However, this tissue is also avascular, aneural and alymphatic with a low cell density embedded within the extracellular matrix (ECM). For these reasons, hyaline cartilage has very modest reparative and regenerative capabilities. Articular cartilage defects are very frequent, especially among active young adults and the working population. Such defects do not heal and, with time, often lead to premature osteoarthritis, consequently decreasing quality of life for the patient and adding substantially to health care costs.
The restoration of damaged cartilage remains one of the biggest challenges in modern orthopaedics. There is no pharmacological treatment that promotes the repair of the cartilage. Current treatment modalities include microfracture, transplantation of ostechondral grafts and chondrocytes, use of biodegradable scaffolds or combination of these. 1, 2 Although these procedures can produce initially good clinical results in terms of pain relief and improvement of joint function, they typically produce a fibrocartilagenouse repair tissue that is inferior to normal cartilage, such that long-term outcomes are less predictable and satisfactory. 3 New biological approaches to cartilage repair that are based on the use of cells and molecules that promote chondrogenesis or/and inhibit cartilage breakdown offer a promising alternative to current treatment options. 4 Any successful strategy that attempts to repair hyaline cartilage defects must include sufficient number of cells, appropriate signal to modulate cellular response and a scaffold that would contain the cells within the defect. Mesenchymal stromal cells (MSCs) present very attractive option for cell-based strategies as they can be readily isolated, expanded and, under appropriate conditions, differentiated into mesenchymal tissues such as cartilage, bone or muscle. 5 Numerous gene products such as transforming growth factor-b (TGF-b), 6 bone morphogenetic protein-7 (BMP-7), 7 insulin-like growth factor-1 (IGF-1) 8 and BMP-2 9 have shown potential in regulating the process of growth, repair and regeneration of cartilage in animal models, but their use is limited by delivery problems and rapid clearance from the joint. This issue can be addressed by gene therapy approaches for delivering therapeutic gene products specifically to the site of repair. 10, 11 In particular, viral vectors have been used successfully to modify graftable articular chondrocytes, periosteal cells and bone marrow-derived MSCs ex vivo, as well as for directly modifying the synovial lining in vivo.
12, 13 The use of scaffolds in cartilage repair is often required to contain, deliver and orient cells within their three-dimensional structure. Many different types have been tested in clinical and experimental settings, but the selection of suitable scaffolds for clinical application is still ongoing.
14 Much of the current research into cartilage repair has focused on ex vivo, or indirect, approaches to the treatment of defects using genetically modified cells. These typically involve harvesting and expansion of the cells, transduction with a therapeutic gene, seeding onto a scaffold and reimplantation into the defect. While providing the aforementioned components for successful cartilage repair, this general approach is technically demanding, expensive and requires at least two surgical procedures. Pascher et al. 15 have recently proposed an abbreviated ex vivo protocol that uses vector-laden, coagulated bone marrow aspirates or 'gene plugs', for gene delivery to cartilage defects. This study showed that nucleated cells within fresh autologous bone marrow aspirates may be successfully transduced with adenoviral vectors sufficient to secret transgene products up to 21 days. In theory, this approach also provides all necessary ingredients for successful cartilage repair: transduced mononuclear cells secrete signals that stimulate mesenchymal progenitors to differentiate along the chondrogenic lineage, and the bone marrow clot (BMC) itself provides a natural autologous three-dimensional scaffold to be used for containment of cells and vectors within the defect.
To examine whether direct implantation of gene plugs might be used in situations that closely mimic real-life clinical situations, partial-thickness chondral defects were created on the weight-bearing surface of the femoral condyle in sheep. Fresh autologous bone marrow aspirates were transduced with adenoviral constructs carrying therapeutic or marker genes, and the clots were press-fit within the defects. The three principle objectives of this study were to determine feasibility of the proposed abbreviated ex vivo protocol to be used as a novel treatment tool in clinical settings, to determine whether transgene expression of TGF-b1 within the gene plug enhances cartilage repair, and to test whether there is a presence of adenoviral genome within the cells of synovial lining, which would suggest vector leakage from the clots.
Results

Histological assessment
The mean scores of the histological assessment are shown in Table 1 , and representative histological sections are shown in Figure 1 . Six months after the surgical procedure, all groups treated with BMC transplantation were superior to empty control in terms of overall score according to the ICRS Visual Histological Assessment Scale, although statistical significance was not observed (P ¼ 0.061) ( Table 1) . Each histological parameter was analysed by Kruskal-Wallis test. A statistically significant difference was observed in one category-columnar cell distribution: TGF and BMC groups had a higher score than the CON group (Table 1) . Although improved fusion between the repair tissue and the surrounding undamaged tissue had been achieved in TGF-treated groups, the side-to-side integrations were far from optimal.
In vitro culturing of genetically modified BMCs
BMCs transduced with green fluorescent protein (Ad.GFP) showed a high number of fluorescent cells throughout the coagulate over 21 days of culture. BMCs formed in the absence of Ad.GFP confirmed the specificity of fluorescence signal.
Biochemical properties
Glycosaminoglycan (GAG) analysis did not reveal any statistical difference between mean values for repaired cartilage in the treatment groups and native cartilage from contralateral knees (P40.050 for all comparisons, paired samples t-test; Figure 2a ). There were no statistically significant differences in GAG mean values for repaired cartilage between the treatment groups (F 2,19 ¼ 0.6, P ¼ 0.581, one-way analysis of variance (ANOVA); Figure 2a ). C Q C Q C Q C Q Surface 0.00 0 0.00 0 0.00 0 0.00 0 0.343 Matrix 1.50 2 3.00 1 3.00 2 3.00 0 0.062 Columnar cell distribution 1.00 c 0 2.00 0 2.00 2 2.00 0 0.016 Cell population viability 0.00 1 1.00 3 0.00 0 0.00 0 0.095 Subchondral bone 2.50 1 3.00 0 3.00 3 3.00 0 0.177 Cartilage mineralization 1.50 3 3.00 0 3.00 3 3.00 0 0.162 Median total score 6.50 6 11.50 4 11.00 9 11.00 0 0. Gene therapy in ovine articular cartilage repair A Ivkovic et al
The collagen type I content was found to be significantly higher in all treatment groups when compared with native cartilage (Po0.050 for all comparisons, paired samples t-test; Figure 1b) . The three treatment groups also significantly differed in collagen type I content (F 2,19 ¼ 13.9, Po0.001, one-way ANOVA; Gene therapy in ovine articular cartilage repair A Ivkovic et al Figure 2b ). Specifically, the collagen type I content in BMC group was significantly lower from that detected in GFP-and TGF-treated groups, respectively (Po0.001 and P ¼ 0.001, respectively, Tukey post hoc test), whereas there was no difference among GFP and TGF groups (P ¼ 0.482, Tukey post hoc test).
The collagen type II content was significantly lower in BMC and GFP treatment groups when compared with native cartilage (Figure 2c ). There was no difference between the GFP and BMC groups (P ¼ 0.079, Tukey post hoc test). Collagen type II content in the TGF group was significantly higher (F 2,19 ¼ 56.2, Po0.001, one-way ANOVA; Figure 2c ) than that detected in GFP-and BMCtreated groups (Po0.001 for both, Tukey post hoc test).
When compared with native cartilage, water content in the repaired tissue was significantly lower in the TGF and GFP groups (Po0.001 and P ¼ 0.005, respectively, paired samples t-test; Figure 2d ), whereas the water content of the TGF group was significantly lower than those detected in the GFP (F 2,19 ¼ 5.9, P ¼ 0.01, one-way ANOVA; Figure 1d ) and BMC groups (P ¼ 0.008, Tukey post hoc test).
Biomechanical properties
Cartilage stiffness at micrometer scale. Dynamic elastic modulus |E*| values for native articular cartilage and reparative cartilage obtained after treatment with gene plugs are shown in Figure 2 . The measurements were obtained with a microspherical tip, nominal radius of 7.5 mm, and they reflect structural changes at the micrometer scale. |E*| micro values gradually increased from native cartilage to the TFG-, BMC-and GFP-treated groups ( Figure 3a ). |E*| micro was significantly higher in all repair groups when compared with native cartilage (BMC Po0.001, GFP P ¼ 0.003, TGF Po0.001, respectively, paired samples t-test). Treatment groups significantly differed in |E*| micro (F 2,19 ¼ 5.3, P ¼ 0.015; oneway ANOVA). |E*| micro from the TGF group was significantly lower than that detected in the GFP group (P ¼ 0.014, Tukey post hoc test). Values from the TGF group also appeared lower compared with those of the BMC group, but no statistically significant difference was observed.
There was a moderately positive association of |E*| micro with water and a moderately negative association with collagen type II, but no correlation with GAG and collagen type I content ( Table 2) .
Cartilage stiffness at nanometer scale. Dynamic elastic modulus |E*| values for native articular cartilage and reparative cartilage are presented in Figure 3b . The measurements were obtained with sharp pyramidal tip, nominal radius of 20 nm, and they reflect structural changes at the nanometer scale. Obtained |E*| nano values suggested that the BMC-treated group had very similar stiffness to native cartilage (P ¼ 0.345, paired samples t-test), but that stiffness was higher in TGF-and GFP-treated groups (P ¼ 0.028 and P ¼ 0.005, respectively, paired samples t-test; Figure 3b ). Furthermore, statistically significant differences in |E*| nano were found between treatment groups (Po0.001, KruskallWallis test). Stiffness was significantly higher in the GFP control group than in the TGF group (P ¼ 0.007, MannWhitney test), whereas BMC had lower |E*| nano when compared with both GFP and TGF (P ¼ 0.001 and P ¼ 0.004, respectively, Mann-Whitney test).
There was a strong positive association of |E*| nano with collagen I content and a moderate negative association with water content, but no correlation with GAG and collagen II content (Table 2) . Gene therapy in ovine articular cartilage repair A Ivkovic et al
Polymerase chain reaction analysis
To determine any expression levels from the gene transfer vectors within the synovial membrane 6 months after surgery, polymerase chain reaction (PCR) was performed using primer sets recognizing the cytomegalovirus (CMV) promoter as well as sheep b-actin. The analysis included five groups of specimens according to treatment, namely TGF-b1 vector-treated, GFP vectortreated as a transduction control, bone marrow treated, empty defect group and controls from contralateral knee. PCR analysis of the synovial tissue revealed no presence of the CMV promoter in any of the treatment groups or the control group 180 days after implantation. Expression of the b-actin gene was detected in all of the analysed samples.
Discussion
It is well known that the healing of focal lesions in adult articular cartilage is very limited and, over time, they may progress to osteoarthritis. Articular cartilage damage is a growing health care problem and a recent study showed that approximately two thirds of patients undergoing knee arthroscopies have been diagnosed with cartilage lesions. 23 On the other hand, the growing armamentarium of novel biological methods and technologies offer scientists and clinicians powerful tools for developing effective new methods in treating damaged cartilage. The cornerstones on which a successful tissue engineering-based strategy will likely be built include an adequate supply of repair cells, sufficient induction of those cells by growth factor signalling, and a biocompatible scaffold conducive to the repair process. 24 The approach to focal cartilage defect repair described in this study uses vector-laden coagulated bone marrow aspirates for gene delivery to the defect site. Aspirated autologous bone marrow contains progenitor cells, the matrix is completely natural and native to the host, and the constitutive fibrin fibres adhere the whole construct to the surface of the defect. Preliminary in vitro and in vivo studies on small animals showed that clotted mixtures of adenoviral suspensions with fresh aspirated bone marrow resulted in levels of transgenic expression in direct proportion to the density of nucleated cells within the clot. 15 This study is a step forward towards a clinical application of these gene plugs to treat local cartilage lesions. The whole study was conceived in a way to simulate potential clinical situation where one would have to treat isolated chondral defect situated on the load-bearing surface of the femoral condyle. Therefore, sheep were chosen for a large animal model. One drawback of the proposed model is the fact that sheep cartilage on the medial condyle is very thin. Ahern et al. 25 performed a detailed systematic review of preclinical animal models in single-site cartilage defect testing. According to their analysis, the ovine cartilage is variable in thickness and it measures from 0.40-1.68 mm. Minor variability in the obtained results might be contributed to that fact, nevertheless, reproducible standardized chondral defects could be created in all animals, using an adapted punch-drill device. For implantation of the gene plugs, standard operation instruments were used. The proposed method proved to be a fairly straightforward technique for application in clinical settings. It is a singlestep operation, which can be easily done by two surgeons within 30-45 min.
The use of TGF-b1-transduced BMCs for articular cartilage defects repair Adult MSCs present a very interesting platform for the development of treatment strategies in orthopaedic tissue engineering. They can be obtained relatively easily from various tissue sources such as bone marrow, fat and muscle, and under appropriate conditions they have the capacity of differentiation into various mesenchymal lineages including bone and cartilage. 5, 26 Numerous in vitro studies showed that primary MSCs undergo chondrogenic differentiation when cultured in the presence of specific media supplements, including dexamethasone and certain extracellular biological cues. 27, 28 TGF-b1 has been used as a key inductor of chondrogenesis in many in vivo and in vitro studies, as it stimulates cell proliferation and synthesis of major components of ECM, GAG and collagen. [29] [30] [31] It was chosen for use in this study because it is one of the best characterized and most potent chondrogenic growth factors. The results of this study showed that all groups that underwent transplantation of BMCs have a high content of GAGs, but only the repair tissue from defects treated with TGF-b1 gene plugs had a very high content of collagen type II similar to native cartilage. The fact that only TGF-treated defects scored statistically higher in terms of columnar cellular distribution suggests that residing mesenchymal progenitors within the gene plug responded to the local expression of TGF-b1 in terms of chondrogenic differentiation, which ultimately resulted in higher ECM turnover and better quality of the cartilage repair. Guo et al. 32 reported similar results in a rabbit model of full-thickness cartilage defects using an ex vivo approach and a chitosan scaffold. Another study by Pagnotto et al. 33 showed improved cartilage repair in osteochondral defects implanted with MSCs transduced with adeno-associated virus (AAV) carrying cDNA for TGF-b1. In their study, transgene expression slowly decreased from 100% at 2 weeks to 17% at 12 weeks, but it proved that gene therapy enables sustained delivery of the bioactive molecules for a period of time that is sufficient to induce and govern cellular response within the defect. Owing to its safe profile, AAV is considered to be the most suitable viral vector for human application, and is currently being tested in a phase I clinical trial. 34 Integration of newly formed cartilage with and neighbouring, undamaged tissue has always been a major issue in cartilage repair. Poor integration causes uneven distribution of mechanical loading, and predisposes the joint surface to the development of early degenerative changes. Although certain improvement in integration was observed in TGF-treated groups, the overall integration is far from being optimal.
Considering that a number of biological factors act in a highly coordinated manner during native tissue development, the use of a single factor to stimulate and regulate process of chondrogenic differentiation, while practical, has limitations with regard to the producing cartilage of optimal quality. Chondrogenesis is a finely regulated process, which includes numerous growth and transcription factors, and a combination of these might Gene therapy in ovine articular cartilage repair A Ivkovic et al be more effective. For example, synergistic effects on chondrogenesis have been reported for TGF-b1 when co-administered with IGF-1. 35 Steinert et al. 36 recently used an aggregate culture system to study effects of co-expression of TGF-b1, IGF-1 and BMP-2 on MSCs. Their results showed larger aggregates, higher levels of GAG synthesis and greater expression of cartilage specific marker genes by adding different combinations of growth factors. Furthermore, it is known that TGF stimulation of MSCs promotes hypertrophy and the increased expression of collagen type I and X. However, Kafienah et al. 37 have shown that including parathyroid hormone-related protein downregulates collagen type I and X in cartilage tissue engineered from MSCs. It should be also noted that some transcription factors such as Sox-9 (which is known to be essential for the full expression of chondrocyte phenotype) and Wnt are not chondrogenic itself, but can make cells more responsive to growth factors and other chondrogenic stimuli. Along these lines, to optimize the proposed method, delivery of multiple genes might be more reliable option, and further studies are needed to pinpoint the exact protocol in terms of concentration and temporal sequence of delivery of chosen genes.
Another important drawback to our study was the fact that we were not able to control weight-loading conditions in the operated animals. Inconsistencies in repair quality within the treatment groups could be attributed to the influence of the weight-loading conditions of the joint immediately after the surgical procedure. In human patients, proper rehabilitation protocols are crucial to optimize the results of bone marrow stimulating as well as cell-based techniques, including postoperative continuous passive motion exercises along with crutchassisted restrictions of weight-bearing up to 6-8 weeks. 38, 39 Practical limitations prevented postoperative ambulation restrictions, possibly allowing detrimental shear forces on the construct and leading to a reduced quality of produced matrix. These limitations might be reflected in the fact that TGF-treated groups had good concentrations of GAGs and collagen II, but very high content of collagen I and low content of water.
Determining biomechanical properties of cartilage repair tissues by indentation-type atomic force microscopy
Biochemical and histological parameters provide information regarding the amount and spatial distribution of the major components comprising repaired cartilage. However, only biomechanical analysis can assess the load-bearing capabilities of the cartilage and therefore biomechanical parameters reflect the functionality of the repaired tissue. To determine load-bearing capabilities of examined tissue, indentation-type atomic force microscopy (IT AFM) was used to determine stiffness-a mechanical parameter that describes the relation between an applied, nondestructive load and resultant viscoelastic deformation of cartilage tissue. Furthermore, biomechanical data with biochemical content was correlated.
Hyaline cartilage is highly specialized tissue with unique three-dimensional structure, which allows it to behave mechanically as a viscoelastic solid. 40 This reflects the unique ultrastructure of cartilage ECM, which is composed of proteoglycans embedded into a network of different types of collagen fibrils. Under cyclic loading, the applied stress and resulting strain are not in phase. To determine stiffness of the cartilage, compressive force is applied and the ratio of stress to strain, the dynamic elastic modulus |E*|, is calculated. Several studies describe the use of probes of varying shape for indentation testing of cartilage where data are typically assessed at millimeter scale. However, this is insufficient to detect local mechanical property variations of the examined tissue that reflect differences in cartilage structural organization at the molecular level. 41, 42 To overcome these limitations, Stolz et al. 22 proposed a novel, AFM-based approach they termed IT AFM. Their protocol enabled absolute measurements of the dynamic elastic modulus |E*| at two different length scales of tissue organization-micrometer and nanometer. This is technically possible because two different probe types are used for these measurements: the microspherical tips for micrometerscale measurements, and sharp pyramidal tips for nanometerscale measurements. In our study, dynamic elastic modulus |E*| nano of the native sheep cartilage is B0.02 MPa, and |E*| micro is B1 MPa, which is in agreement with studies performed on human cartilage, where stiffness values averages around 0.015 and 2.6 MPa, respectively, for healthy individuals without OA. 43, 44 According to Stolz et al., this 100-fold modulus difference between micrometer and nanometer scale is a result of assessing different levels of cartilage hierarchical organization. On the micrometer scale, articular cartilage behaves as relatively amorphous material, whereas at the nanometer scale, ultrastructural differences are resolved.
Microstiffness values were lowest for native cartilage and gradually rose from TGF-and BMC-to GFP-treated groups, respectively (Figure 2 ). This would suggest that the repair tissue of the TGF-treated group is qualitatively superior to the other two groups showing biomechanical properties close to native cartilage. However, nanoscale measurement showed that the BMC-treated group has very similar nanostiffness to that of native cartilage, and the stiffness values of the TGF-and GFP-treated groups are much higher (Figure 3) . We hypothesized that this observation could reflect different amounts and spatial orientation of newly synthesized extracellular components and/or water content within the repair tissue in the last two groups. To test this hypothesis, correlation analysis was performed, which showed that the dynamic elastic modulus |E*| micro correlated moderately positively with water and moderately negatively with collagen type II, but not with GAG and collagen type I content (Table 2) . At the same time, |E*| nano correlates strongly positive with collagen type I and moderately negative with water, but not with GAG and collagen type II content (Table 2) . At the micrometer level, biomechanical properties of cartilage repair tissue are only moderately correlated with the biochemical content. This observation leads us to conclusion that, at micrometer level of tissue organization, it is not possible to determine contribution of individual ECM components to biomechanical properties of repaired cartilage. However, at the nanometer level, dynamic elastic modulus correlates with collagen I content, which is barely present in native cartilage. A sharp AFM tip has nominal radius of 20 nm that is smaller than an individual collagen fibril, Gene therapy in ovine articular cartilage repair A Ivkovic et al which typically measures around 50 nm. 22 Although microspherical tip is too big to detect subtle differences in orientation and amount of collagen fibrils, sharp pyramidal tip can discriminate such differences, resulting in higher stiffness values.
Presence of adenoviral vector in the surrounding synovial lining
The use of viral-based gene therapy is controversial with regards to safety. Although very effective in terms of gene transfer and expression, viral vectors induce immune response and their presence in the surrounding tissue may result with detrimental side effects. For example, TGF-b1 administered into the joint in sufficient concentrations can lead to chondrophyte formation at the joint margins, which at later stages calcify and become real osteophytes. 45 One of the major goals of this study was to determine whether there is any residual presence of virus within the synovium. After killing the animals, joints were inspected for any signs of osteophyte formation and/or arthrofibrosis, but none was detected. Although PCR analysis of the synovial lining tissue could not detect the residual presence of transgene in any of the experimental groups, suggesting that the virus is well contained within the clot, this information should be taken cautiously. Given what is known about the immune response to adenovirus and adenovirally modified cells, it is possible that any modified cells within the synovial tissue were cleared after 6 months. Future studies should use additional procedures, such as measure of elevated cytokines from lavage fluid during the first weeks following surgery, as a more sensitive indication of undesired side effects within the joint. The next generation of improved gene vehicles, such as those based on recombinant AAV (rAAV), might be more suitable for cartilage repair than the first generation adenoviral vectors used in this study. In comparison to adenovirus, rAAV is less immunogenic, and the reduced risk of adverse reactions is a substantial advantage favouring the use of this class of vector. 20 In conclusion, this study systematically explored the benefits and pitfalls of the novel technique to treat local cartilage defects by using gene plugs in clinical settings. In contrast to more complex approaches in tissue engineering, we advocate the use of simpler methods that harness the intrinsic regenerative potential of endogenous tissues, using biological stimuli to initiate and promote natural healing in situ. This concept has been termed facilitated endogenous repair by Evans et al. 46 and the ultimate goal is to enable clinicians to use tissue engineering that is not only successful but also cheap, safe and clinically expeditious. The proposed method is a single-step procedure that can be easily implemented in standard clinical settings, avoids the usual drawbacks associated with gene therapy because it is administered locally, and excludes the expensive in vitro production of autologous and engineered tissues.
Materials and methods
Vector construction
The first generation recombinant vectors used in this study originated form replication-deficient type 5 adenovirus lacking E1 and E3 loci (Ad.). 16 Vectors directing overexpression of TGF-b1 (Ad.TGF-b1) and Ad.GFPeach driven by the CMV promoter-were constructed by Cre-lox recombination using the system of Hardy et al.
17
These adenoviral vectors were propagated in 293-CRE8 cells and purified on three successive CsCl 2 density gradients between 1.2 and 1.4 g ml À1 . Following dialysis in 10 mM Tris-HCL, pH 7.8, 150 mM NaCl, 10 mM MgCl 2 and 4% sucrose, the preparations were aliquotted and stored at À80 1C. Viral titers were estimated by optical density and standard plaque assay.
Animals
Twenty-eight skeletally mature sheep (female, 1-3 years old) were used for this study. The sheep were randomly assigned to one of the four groups. In the BMC group (n ¼ 6), the sheep were implanted with untreated autologous BMC that was aspirated from iliac crest of respective animal. In the GFP group (n ¼ 6), autologous BMCs genetically modified with Ad.GFP were implanted in sheep as a vector control. In the TGF-b1-treated (TGF) group (n ¼ 10), autologous BMCs genetically modified Ad.TGF-b1 were implanted in the sheep. In the negative control (CON) group (n ¼ 6), defects were left empty. Native cartilage from the contralateral knee was harvested from each animal and compared with the repair tissue of the defect sites. The experimental protocol was approved by the local Animal Experiment Ethical Committee.
Anaesthesia protocol
The sheep were operated on under general anaesthesia and aseptic conditions. The premedication was performed with 0.1 mg kg À1 of intramuscular xylazine (Xylapan, Vetoquinol, Bern, Switzerland) and cephalic vein was prepared for administration of drugs. Induction of anaesthesia was performed intravenously with 2.5% solution of thiopentale sodium (Thiopental, Nycomed, Ismaning, Germany) in a dose 5 mg kg À1 and small boluses of drug were administered until the jaws were relaxed for endotracheal intubation. Cefuroxime (Ketocef, Pliva, Zagreb, Croatia) was administered perioperatively. Carprofen (Rymadil, Pfizer Animal Healthcare, Exton, PA, USA) was administered postoperatively in a dose of 2 mg kg À1 .
Surgical procedure
Medial parapatellar arthrotomy was performed on the right knee of each animal, and both condyles were exposed. A standardized partial-thickness chondral defect of 6.2 mm in diameter (Figures 4a and b) was made on the weight-bearing surface of the medial condyle using a punch-drill device adapted from mosaicplasty instrumentation (Smith & Nephew Inc., Andover, MA, USA). Special care was taken not to damage the subchondral bone, as well as to create sharp edges at the border of the defects that were perpendicular to the joint surface. Defects were then treated as described below.
Press-fit implantation of gene plugs and native bone marrow plugs into the defects
Under sterile surgical conditions, 3 ml of bone marrow was aspirated form the right iliac crest of an anaesthetized sheep using a TrapsystemSet (H-S Medical Inc., Gene therapy in ovine articular cartilage repair A Ivkovic et al Boca Raton, FL, USA) and a 16-g needle. Using a 1-ml micropipette, aliquots of 250 ml were rapidly mixed with 25 ml suspension of 1 Â 10 10 viral particles of Ad.GFP or Ad.TGF-b1. The mixtures were pipetted into the defects and immediately covered with a paper to build a chamber and allow coagulation in situ for 5 min. The paper was then removed, and the implants were rinsed with saline solution and checked for stability by repetitive flexion and extension of the knee. The joint was closed by suturing in two layers (Figures 4c and d) .
Gene transfer to BMCs for in vitro culture
A portion of bone marrow aspirate obtained from iliac crest (as described in previous paragraph) was used to generate genetically modified BMCs for in vitro culture. Using a 1-ml micropipette, aliquots of 250 ml of bone marrow aspirate were rapidly mixed with 25 ml suspension of 1 Â 10 10 viral particles of Ad.GFP. Following coagulation, the BMCs were removed from the vessel, and placed in individual wells of 24-well plates with 0.5 ml of DMEM with 10% FBS and 1% penicillin/ streptomycin. Media were replaced every 3 days. Clots were maintained in this manner for 21 days until analysed with fluorescence microscopy. Native BMCs were used as negative controls. This parallel set of in vitro cultures served as indirect proof of transgenic expression within the transplanted gene plugs.
Harvesting the samples
Six months after surgery, all sheep were killed by intravenous injection of an overdose of barbiturate. The medial condyle containing the cartilage defect was removed and divided into two halves using a cooled saw: one being used for histology and one for biochemistry and biomechanical testing. Undamaged articular cartilage was taken from the medial condyle of the contralateral knee joint for comparison with treated condyles. The specimens for histology, biochemical and biomechanical analysis were prepared as described below. Synovial lining specimens were also taken from each joint and stored in liquid nitrogen for PCR analysis.
Morphologic analysis-histology
The osteochondral samples fixed for histology were decalcified in 10% ethylenediaminetetraacetic acid. The samples were dehydrated in alcohol, embedded in paraffin and sectioned at 5 mm. Sections were stained with haematoxylin and eosin to evaluate morphology, and safranin-O to assess proteoglycan distribution in the pericellular matrix. Slides were examined by two blinded observers using light microscopy and graded semiquantitatively using the ICRS Visual Histological Assessment Scale. 18 The scoring system was based on articular surface morphology, matrix composition, cellular distribution, cell population viability, subchondral bone morphology and cartilage mineralization.
Quantitative biochemical characterization
Samples were frozen and stored at À80 1C until ready for analysis. Wet and dry weights of the cartilage or repair tissue were determined before and after freeze drying. The samples were then solubilized using digestion with trypsin and processed for complete biochemical analysis, as described by Dickinson et al.
19
Each sample was milled in liquid nitrogen using a stainless steel percussion mortar and pestle, to obtain a fine particulate, and weighed after freeze drying to obtain the dry weight. Bovine pancreatic trypsin was prepared at 2 mg ml À1 in Tris buffer (pH 7.5) containing 1 mM iodoacetamide, 1 mM ethylenediaminetetraacetic 
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A Ivkovic et al acid and 10 mg ml À1 pepstatin A (all from SigmaAldrich, St Louis, MO, USA). An initial incubation for 15 h at 37 1C with 250 ml trypsin was followed by further 2 h incubation at 65 1C after the addition of a further 250 ml of the freshly prepared proteinase. All samples were boiled for 15 min at the end of incubation to destroy any remaining enzyme activity.
Type I collagen. The digests were assayed using inhibition enzyme-linked immunosorbent assay using a rabbit antipeptide antibody to type I collagen, as described earlier. 19 Type II collagen. The digests were assayed using inhibition enzyme-linked immunosorbent assay using a mouse immunoglobulin G monoclonal antibody to denatured type II collagen, COL2-3/4 m, as described earlier, but modified for use on 384-well plates to allow the use of a smaller volume of sample than is required for a 96-well plate. 20 Glycosaminoglycans. A previously described colorimetric assay for GAG was modified for use on 384-well plates to allow the use of a smaller volume of sample than is required for a 96-well plate.
19,21
Water content. The percentage of water was calculated by subtracting the dry weight of the sample and dividing the difference by the wet weight.
PCR analysis
To detect the presence of adenoviral genome in the synovial lining, PCR analysis was performed. Synovial membranes of the joints were digested with proteinase K for 4 h at 37 1C. Total DNA was then extracted using a DNeasy Tissue kit (Qiagen, Valencia, CA, USA), following the manufacturer's instructions. Amplification of the CMV promoter sequence within the vectors as well as the sheep b-actin gene was performed using the following primers: CMV forward 5 0 -TCATATGCCAAGT ACGCCCCC-3 0 , reverse 5 0 -TGGGGCGGAGTTGTTACG AC-3 0 ; b-actin forward 5 0 CATGCCATCCTGCGTCTGG ACC-3 0 , b-actin reverse 5 0 TACTCCTGCTTGCTGATCC ACATCTGC-3 0 . Amplification products were visualized on agarose gel with ethidium bromide.
Biomechanical properties
Biomechanical properties of the repair tissue compared with regular cartilage from the contralateral knee was assessed by IT AFM of 2 mm diameter samples, harvested using a skin biopsy punch and scalpel. Care was taken to include the full thickness of the repair tissue but to exclude any subchondral bone. The specimens were then stored in the cold room at 41 Celsius in PBS supplemented with protease inhibitor cocktail (Complete, Boehringer Mannheim, Germany).
Mechanical properties (that is, stiffness) of articular cartilage and repair tissue were determined by measurements of |E*|, the dynamic elastic modulus of articular cartilage, at two different length scales of tissue organization: micrometer (|E*| micro ) and nanometer (|E*| nano ). Preparation of the cartilage samples, data acquisition and processing was done as described by Stolz et al. 22 Briefly, spherical tips with radius of 7.5 mm (SPI Supplies, West Chester, PA, USA) were mounted onto the end of rectangular tipples silicon nitride cantilevers having nominal spring constants of 0.35 N m À1 (MicroMasch, San Jose, CA, USA) and used for micrometer-scale experiments. For nanometer-scale experiments, square-based pyramidal silicon-nitride tips with a nominal tip radius of 20 nm were used on V-shaped 200-mm-long silicon nitride cantilevers with a nominal spring constant of 0.06 N m À1 (Veeco Instruments Inc., Plainview, NJ, USA). The IT AFM was operated in the force-volume mode, where the loaddisplacement curves were recorded at five different sites on the sample surface at a frequency of 3 Hz with scan areas of 0 Â 0 mm and 10 Â 10 mm. Data sets recorded at any given sample site consisted of 256 load-displacement curves (each curve consisting of 512 data points), which were analysed to compute the dynamic elastic modulus |E*|.
Statistics
A Kolmogorov-Smirnov test was used to test distributions of biochemical (GAG, collagen I, collagen II and water) and biomechanical data (|E*| micro and |E*| nano ) for normality. Distributions were normal for all data sets except for |E*| nano . Therefore, parametric tests were used to analyse all biochemical and biomechanical data, whereas elastic modulus data were analysed by nonparametric testing. Biochemical and biomechanical properties of repaired cartilage were expressed as the mean (M) ± s.d. As the contralateral knee in each animal served as its own control, a two-tailed paired samples t-test was used to compare treatment versus control groups. Data from each test subsets were compared by one-way ANOVA with Tukey post hoc test where required. To analyse |E*| nano , results, we used Wilcoxon matched pairs test as a nonparametric equivalent of the paired samples t-test and Kruskal-Wallis and Mann-Whitney tests as equivalents of ANOVA and Tukey post hoc. Nonparametric tests were also used to analyse semiquantitative histological scores. Association between biomechanical properties and biochemical content were determined using Spearman correlation. Statistical significance was set at Po0.05. All analyses were performed using SPSS 17.0 for Windows (SPSS Inc., Chicago, IL, USA).
